Avantor

Avantor® Reports First Quarter 2024 Results

Retrieved on: 
Friday, April 26, 2024

We are reaffirming fiscal year 2024 guidance and remain focused on executing our long-term growth strategy," Stubblefield concluded.

Key Points: 
  • We are reaffirming fiscal year 2024 guidance and remain focused on executing our long-term growth strategy," Stubblefield concluded.
  • For the three months ended March 31, 2024, net sales were $1.68 billion, a decrease of 5.6% compared to the first quarter of 2023.
  • Net sales were $1,157 million, a reported decrease of 3.8%, as compared to $1,203 million in the first quarter of 2023.
  • We will host a conference call to discuss our results today, April 26, 2024, at 8:00 a.m. Eastern Time.

BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

Retrieved on: 
Tuesday, April 9, 2024

The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately.

Key Points: 
  • The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately.
  • Ms. Lewis will report to BeautyHealth’s President and Chief Executive Officer, Marla Beck.
  • “Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company,” said Marla Beck, BeautyHealth President and Chief Executive Officer.
  • Most recently, Ms. Lewis was the EVP of global supply chain operations at Avantor, Inc., where she served on the executive committee and led the company’s global integrated supply chain strategy and operational performance with oversight of over 3,500 associates.

Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024

Retrieved on: 
Monday, April 1, 2024

RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.

Key Points: 
  • RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.
  • To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
  • A replay of the webcast will be available for 30 days.

Avantor® Celebrates Supplier Award Honorees at 2024 European Sales Conference

Retrieved on: 
Monday, February 26, 2024

The event brought together Avantor's European sales organization and the Company's supplier partners and focused on collaboration to deliver an exceptional customer experience.

Key Points: 
  • The event brought together Avantor's European sales organization and the Company's supplier partners and focused on collaboration to deliver an exceptional customer experience.
  • As part of the event, the Avantor Supplier Award honorees were celebrated for distinguished product quality, collaboration, operational excellence, marketing, and overall performance.
  • "The European Sales Conference is a valuable opportunity to connect with our supplier partners who play a crucial role from discovery to delivery in providing choice and innovation to our customers.
  • The European sales organization selected BINDER GmbH as the Supplier of the Year for 2024.

Avantor® to Participate in the 44th Annual TD Cowen Health Care Conference

Retrieved on: 
Tuesday, February 20, 2024

RADNOR, Pa., Feb. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m. Eastern Standard Time.

Key Points: 
  • RADNOR, Pa., Feb. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m. Eastern Standard Time.
  • To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
  • A replay of the webcast will be available for 30 days.

Avantor® Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, February 14, 2024

RADNOR, Pa., Feb. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • For the three months ended December 31, 2023, net sales were $1.72 billion, a decrease of 4.0% compared to the fourth quarter of 2022.
  • Net sales were $994.8 million, a reported decrease of 5.1%, as compared to $1,048.0 million in the fourth quarter of 2022.
  • Net sales were $603.5 million, a reported decrease of 2.2%, as compared to $617.2 million in the fourth quarter of 2022.
  • Net sales were $124.5 million, a reported decrease of 4.1%, as compared to $129.8 million in the fourth quarter of 2022.

Avantor® to Report Fourth Quarter and Full Year 2023 Earnings on Wednesday, February 14, 2024

Retrieved on: 
Wednesday, January 24, 2024

RADNOR, Pa., Jan. 24, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February, 14, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.

Key Points: 
  • RADNOR, Pa., Jan. 24, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February, 14, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.
  • To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
  • A replay of the webcast will be available for 30 days.

Avantor® Recognizes Supplier Award Winners at 2024 Americas Sales Conference

Retrieved on: 
Friday, January 19, 2024

Supplier recognition is a key highlight of the conference, and the Avantor Supplier Awards recognizes excellence across a range of categories and product segments.

Key Points: 
  • Supplier recognition is a key highlight of the conference, and the Avantor Supplier Awards recognizes excellence across a range of categories and product segments.
  • The 2024 Supplier of the Year award is nominated by the Avantor sales organization, honoring the supplier's outstanding product, field support and marketing programs.
  • "Avantor's Americas Sales Conference is an opportunity to recognize the contributions and achievements of our suppliers and deepen collaboration with our sales organization.
  • Congratulations to all of our award winners," said Jim Bramwell, Executive Vice President, Sales and Customer Excellence at Avantor.

Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board

Retrieved on: 
Monday, January 8, 2024

BOSTON, Jan. 8, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the formation of its new Biopharma Advisory Board.

Key Points: 
  • BOSTON, Jan. 8, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the formation of its new Biopharma Advisory Board.
  • "The discovery and development of new medicines is critically important and incredibly challenging," said Jason Kelly, co-founder and CEO of Ginkgo Bioworks.
  • "I'm excited to welcome this incredible deep bench of wisdom and creativity to the Ginkgo family," said Jennifer Wipf, SVP & Head of Commercial at Ginkgo Bioworks.
  • Now more than ever, the speed of drug discovery and development is important," said Norbert Bischofberger, Ginkgo Biopharma Advisory Board member.

Avantor® to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 3, 2024

RADNOR, Pa., Jan. 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that Michael Stubblefield, President and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco on Monday, January 8, 2024 at approximately 9:45 a.m. Pacific Time.

Key Points: 
  • RADNOR, Pa., Jan. 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that Michael Stubblefield, President and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco on Monday, January 8, 2024 at approximately 9:45 a.m. Pacific Time.
  • To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
  • A replay of the webcast will be available for 30 days.